33). In the breast cancer context, on the other hand, it has been observed that PARP12 is an active contributor of IFN/STAT1 signalling pathway involved in post-chemotherapy survival and re-growth of breast cancer cells (Ref. 34). The gene discussed is PARP12; the disease is breast carcinoma.